The present invention includes methods of reducing the activity, such as enzymatic activity and expression, of mitogen-activated protein kinase-activated protein kinase 2. The present invention further includes methods for identifying compounds useful for reducing such activity, and methods for reducing ischemic injury by the administration of such compounds.
申请公布号
WO2004017909(A2)
申请公布日期
2004.03.04
申请号
WO2003US26337
申请日期
2003.08.21
申请人
BRISTOL-MYERS SQUIBB COMPANY;WANG, XINKANG;SCHIEVEN, GARY;FEUERSTEIN, GIORA, Z.
发明人
WANG, XINKANG;SCHIEVEN, GARY;FEUERSTEIN, GIORA, Z.